Westborough, MA, United States of America

Guangping Gao

This inventor holds 120 USPTO granted patents and 87 published patent applications, plus 17 CIPO patents and 38 EPO patents, primarily in Gene Therapy (CPC class C12N2750-14143). Top assignees: University of Massachusetts, University of Pennsylvania, The Clinic for Special Children. Active years: 2002-2026.

USPTO Granted Patents = 120 (Patent Applications = 87)

% Patents Active = 80.8

CIPO Patents = 17 (Patent Applications = 7)

EPO Patents = 38 (Patent Applications = 81)

Average Co-Inventor Count = 2.8

ph-index = 35

Forward Citations = 3,801(Granted Patents)

Forward Citations (Not Self Cited) = 2,772(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Rosemont, PA (US) (2002 - 2015)
Westborough, MA (US) (2011 - 2024)
Worcester, MA (US) (2019 - 2024)

Company Filing History:

64 out of 1,623

University of Massachusetts

patents

54 out of 2,645

University of Pennsylvania

patents

2 out of 3

The Clinic for Special Children

patents

4. 1 out of 1

Adrenas Therapeutics, Inc.

patent

5. 1 out of 274

Massachusetts Eye and Ear Infirmary

The General Hospital Corporation

patents

8. 1 out of 2

The Trustees of the University of Pennsylavania

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

AAV Vectors

Gene Replacement Therapy

Metabolic Imbalance

Neurodegenerative Disease

Viral Vector Production

Recombinant AAV

Minigene Therapy

Anti-Angiogenic miRNA

Transgene Expression

Bone Disorders

Cancer Treatment

Cholesterol Disorders

120 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723249 - AAV PRODUCTION STRATEGY USING A CELL LINE EXPRESSING AN INDUCIBLE REP GENE (2026-09-01),

2. 12636382 - PROSTATE TARGETING ADENO-ASSOCIATED VIRUS SEROTYPE VECTORS (2026-05-26),

3. 12570997 - FACTOR H VECTORS AND USES THEREOF (2026-03-10),

4. 12553063 - CAS13 family AAV vectors and uses thereof (2026-02-17),

5. 12553036 - GM3 SYNTHASE VECTORS AND USES THEREOF (2026-02-17),

6. 12497612 - GENE REPLACEMENT THERAPY FOR FOXG1 SYNDROME (2025-12-16),

7. 12491235 - METHODS AND COMPOSITIONS FOR TREATING METABOLIC IMBALANCE IN NEURODEGENERATIVE DISEASE (2025-12-09),

8. 12478692 - GENE THERAPY FOR SPINAL MUSCULAR ATROPHY (2025-11-25),

9. 12467063 - RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS (2025-11-11),

10. 12454702 - Minigene therapy (2025-10-28),

11. 12398378 - AAV-mediated gene therapy for maple syrup urine disease (MSUD) (2025-08-26),

12. 12390539 - Minigene therapy (2025-08-19),

13. 12371710 - Modified AAV constructs and uses thereof (2025-07-29),

14. 12344857 - Viral vector production (2025-07-01),

15. 12195767 - Adeno-associated virus gene therapy for 21-hydroxylase deficiency (2025-01-14),

Title: The Innovative Journey of Inventor Guangping Gao

Introduction: Guangping Gao, a distinguished inventor based in Westborough, MA (US), has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Guangping Gao holds several patents in the areas of biotechnology and gene therapy, showcasing his expertise and commitment to advancing scientific research and development.

Career Highlights: With a career spanning over two decades, Guangping Gao has established himself as a leading figure in the world of inventions. His pioneering work in gene therapy has revolutionized the way we approach genetic disorders and diseases.

Collaborations: Throughout his career, Guangping Gao has collaborated with top research institutions, universities, and biotechnology companies to further his research and bring his inventions to life. His collaborative spirit has led to numerous successful projects and innovations.

Conclusion: Guangping Gao's passion for innovation and dedication to scientific advancement have solidified his reputation as a visionary inventor. His work continues to inspire and shape the future of biotechnology and gene therapy.